Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
240 Leser
Artikel bewerten:
(0)

Global Elemental Analysis Market 2014-2017 & 2025 - Key Players are PerkinElmer, Thermo Fisher Scientific, Agilent Technologies, Shimadzu and Analytik Jena

DUBLIN, November 28, 2017 /PRNewswire/ --

The "Elemental Analysis Market By Type of Elements (Organic, Inorganic), By Technology (Destructive Technologies, Non-destructive Technologies), By Region, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global elemental analysis market is expected to reach USD 2.02 billion by 2025, growing at a CAGR of 6.2%

The market is primarily driven by amendments in the ICH (International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) regulations that mandate use of elemental analysis for finished medical products, including pharmaceuticals.

Many manufacturers of elemental analyzers invest in R&D of new and technologically advanced products. In addition to their expenses for R&D, many key players launched new products in the market in the past 3 years. For instance, in May 2016, Agilent Technologies launched Agilent 5110 ICP-OES, which was designed to enable scientists perform fast and precise elemental analysis of pharmaceuticals and food products along with mining, industrial, and environmental analysis.

In addition, in many countries, the limit of heavy metals/trace elements is regulated by their respective pharmacopeias. For instance, United States, Japanese, and European pharmacopeias limit the amount of trace elements in finished pharmaceutical products. Furthermore, elemental analysis is a crucial step before commercial launch of a medical product in the market.

North America held the largest market share in 2016. Local presence of large number of manufacturers, regulation of limits of trace elements/heavy metals by United States Pharmacopeia (USP), and ongoing research for development of new products are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. Rise in interest of market players to expand their business in Asia Pacific, growing awareness on safety of pharmaceuticals, and increase in expenditure by local pharmaceutical companies on elemental analyzers are factors that can be attributed for the highest growth rate of Asia Pacific region during the forecast period.

Further Key Findings From the Report Suggest:

  • The inorganic elements segment held the largest revenue share in 2016 due upcoming mandates for elemental analysis in medical products
  • Nondestructive technologies held the largest revenue share of the market, by technology, in 2016. Retention of sample after analysis and high precision rate can be the key factors for largest share of this segment
  • North America dominated the global market due to presence of USP regulations that limit the amount of heavy metals/trace elements
  • Some of the key players are PerkinElmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and Analytik Jena AG; among others

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Elemental Analysis Market Variables, Trends & Scope

Chapter 4 Elemental Analysis Market: Type Of Elements Estimates & Trend Analysis

Chapter 5 Elemental Analysis Market: Technology Estimates & Trend Analysis

Chapter 6 Elemental Analysis Market: Regional Estimates & Trend Analysis, By Type Of Elements And By Technology

Chapter 7 Competitive Landscape

  • Thermo Fisher Scientific, Inc.
  • Perkin Elmer.
  • Analytik Jena AG (acquired by Endress+Hauser Management AG)
  • Agilent Technologies, Inc.
  • Elementar Analysensysteme GmbH
  • Shimadzu Corporation
  • Rigaku Corporation

For more information about this report visit https://www.researchandmarkets.com/research/lc7zg3/elemental

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.